Document is current
Any future updates will be listed below
-
Authors
Pomatto-Watson, Laura C. D.
Bodogai, Monica
Bosompra, Oye
Kato, Jonathan
Wong, Sarah
Carpenter, Melissa
Duregon, Eleonora
Chowdhury, Dolly
Krishna, Priya
Ng, Sandy http://orcid.org/0000-0002-4232-7410
Ragonnaud, Emeline
Salgado, Roberto http://orcid.org/0000-0002-1110-3801
Gonzalez Ericsson, Paula http://orcid.org/0000-0002-6292-6963
Diaz-Ruiz, Alberto http://orcid.org/0000-0002-0488-4216
Bernier, Michel http://orcid.org/0000-0002-5948-368X
Price, Nathan L.
Biragyn, Arya
Longo, Valter D. http://orcid.org/0000-0002-0946-7534
de Cabo, Rafael http://orcid.org/0000-0002-3354-2442
- License Information
-
More Information
Article History
Received: 4 January 2021
Accepted: 7 October 2021
First Online: 27 October 2021
Competing interests
: The experimental FMD diet was provided by L-Nutra, Inc. The funding sources had no involvement in study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication. USC has licensed intellectual property to L-Nutra that is under study in this research. As part of this license agreement, the University has the potential to receive royalty payments from L-Nutra. V.D.L. who has equity interest in L-Nutra, did not participate in the collection and analysis of the data. One-hundred percent of V.D.L.’s equity will be assigned to the nonprofit foundation Create Cures. R.S. reports non-financial support from Merck and Bristol Myers Squibb, research support from Merck, Puma Biotechnology, and Roche and personal fees from Roche for an advisory board related to a trial-research project. He has no conflict of interest related to this work. The remaining authors have no competing interest to declare.
